Wave Life (WVE) Shares Nearly Triple on Encouraging Obesity Drug Trial
We recently published 10 Stocks Delivering Explosive 18-190% Gains. Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the last week’s heavy gainers. Wave Life Sciences nearly tripled its share price on a week-on-week basis, as investors positioned their portfolios after the encouraging results of its obesity drug clinical trial, sparking rosy prospects for the company in a highly coveted industry. At intra-week trading, Wave Life Sciences Ltd. (NASDAQ:WVE) soared by as much as 190 percent to touch a new si ...